BofA DMD Expert Call Positions Sarepta Therapeutics (SRPT) Ahead of Pfizer (PFE)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.70 +0.70 (2.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.00 | 52 Week High | $37.39 | |||
| Open | $30.75 | 52 Week Low | $28.25 | |||
| Day High | $30.90 | P/E | 18.61 | |||
| Day Low | $30.04 | EPS | $1.65 | |||
| Volume | 31,724,260 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 18.94 +0.40 (2.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.54 | 52 Week High | $63.73 | |||
| Open | $18.94 | 52 Week Low | $8.00 | |||
| Day High | $19.28 | P/E | N/A | |||
| Day Low | $18.52 | EPS | $-5.69 | |||
| Volume | 735,213 | |||||
